Spinal Cord Injuries in Dogs Part II: Standards of Care, Prognosis and New Perspectives
Author:
Šulla I.1, Balik V.2, Horňák S.3, Ledecký V.3
Affiliation:
1. Department of Anatomy, Histology and Physiology , University of Veterinary Medicine and Pharmacy , Komenského 73, 041 81 Košice , Slovakia 2. Institute of Molecular Medicine and Translational Medicine, University Hospital and Faculty of Medicine and Dentistry , Palacky University , I. P. Pavlova 6, 772 20 Olomouc , Czechia 3. Small Animal Clinic , University of Veterinary Medicine and Pharmacy , Komenského 73, 041 81 Košice , Slovakia
Abstract
Abstract
Severe spinal cord injuries (SCI), causing physical handicaps and accompanied by many serious complications, remains one of the most challenging problems in both, human and veterinary health care practices. The central nervous system in mammals does not regenerate, so the neurological deficits in a dog following SCI persists for the rest of its life and the affected animals display an image of permanent suffering. Diagnostics are based on: neurological examination, plain x-rays of vertebral column, x-rays of the vertebral column following intrathecal administration of a water-soluble contrast medium (myelography), x-rays of the vertebral column following epidural administration of a contrast medium (epidurography), computed tomography (CT) and/or magnetic resonance imaging (MRI). Currently, only limited therapeutic measures are available for the dogs with SCIs. They include: the administration of methylprednisolone sodium succinate (MPSS) during the acute stage; early spinal cord decompression; stabilisation of vertebral fractures or luxations; prevention and treatment of complications, and expert rehabilitation. Together with the progress in the understanding of pathophysiologic events occurring after SCI, different therapeutic strategies have been instituted, including the local delivery of MPSS, the utilisation of novel pharmacological agents, hypothermia, and stem/precursor cell transplantation have all been tested in the experimental models and preclinical trials with promising results. The aim of this review is the presentation of the generally accepted methods of diagnostics and management of dogs with SCIs, as well as to discuss new therapeutic modalities. The research strategy involved a PubMed, Medline (Ovid), Embase (Ovid) and ISI Web of Science literature search from January 2001 to December 2017 using the term “spinal cord injury”, in the English language literature; also references from selected papers were scanned and relevant articles included.
Publisher
Walter de Gruyter GmbH
Reference77 articles.
1. 1. Adams, M. M., Hicks, A. L., 2005: Spasticity after spinal cord injury. Spinal Cord, 43, 577—586. 2. 2. Akhtar, A. Z., Pippin, J. J., Sandusky, C. B., 2008: Animal models in spinal cord injury: a review. Rev. Neurosci., 19, 47—60. 3. 3. Badner, A., Vawda, R., Laliberte, A., Hong, J., Mikhail, M., Jose, A., et al., 2016: Early intravenous delivery of human brain stromal cells modulates systemic inflammation and leads to vasoprotection in traumatic spinal cord injury. Stem Cells Transl. Med., 5, 991—1003. 4. 4. Bockurt, G., Mothe, A. J., Zahir, T., Kim, H., Shoichet, M. L., Tator, C. H., 2010: Chitosan channels containing spinal cord-derived stem/progenitor cells for repair of subacute spinal cord injury in the rat. Neurosurgery, 67, 1733—1744. 5. 5. Borrie, S. C., Baeumer, B. E., Badtlow, C. E., 2012: The nogo-66 receptor family in the intact and diseased CNS. Cell Tissue Res., 349, 105—117.
Cited by
2 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
|
|